MOLLY OSWALD: Open Payments
NPI 1285145672 · LOS ANGLES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 8 payments from 4 companies in 2025. Trend: 2023 $721 · 2024 $274 · 2025 $1,118
Consulting: $660Food & beverage: $435Education: $23
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 2 | $748 |
| Janssen Biotech, Inc. | 2 | $252 |
| Axsome Therapeutics, Inc. | 3 | $95 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
Products named: Orserdu, RYBREVANT, Auvelity, ELZONRIS.
Industry payments across CA — which companies pay providers there.
